scout
|Videos|February 9, 2017

A Study of Chemotherapy With Durvalumab and Tremelimumab in NSCLC

Rosalyn Juergens, MD, PhD, assistant professor, Department of Oncology, Division of Medical Oncology, McMaster University, discusses a clinical trial investigating chemotherapy with durvalumab and tremelimumab in patients with non-small cell lung cancer (NSCLC).

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME